MedTrace Logo

The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions

NCT05924763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-09-25

No results posted yet for this study

Summary

Based on the previous successful experiences, the investigators like to extend our patient population. In this study, the investigators aim to determine the safety and effectiveness of the Biphasic Cartilage Repair Implant (BiCRI) in the treatment of chondral and osteochondral lesions of the knee, including but not limited to more than one (1) lesion and the lesion that had been treated with microfracture or mosaicplasty but failed.

Conditions

  • Articular Cartilage Disorder of Knee

Interventions

DEVICE

Biphasic Cartilage Repair Implant (BiCRI)

The Biphasic Cartilage Repair Implant (BiCRI) is a two-phase scaffold composed of poly(lactic-co-glycolic acid) (PLGA) and β-triCalcium phosphate (TCP).

Sponsors & Collaborators

  • BioGend Therapeutics Co.Ltd

    lead INDUSTRY

Principal Investigators

  • Gwen Chang · BioGend Therapeutics Co.Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2022-06-10
Completion
2022-08-18

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924763 on ClinicalTrials.gov